Maria Key Prato
0000-0003-4421-1160
Publication & Citation Trends
Publications
7 total
Putting Patient Voices at the Heart of Healthcare Decisions: The UNIFIED Public-Private Project
Cited by 0
Semantic Scholar
Optimizing the MDS-UPDRS Part III for early-stage Parkinson’s: early supportive evidence for a limb-related bradykinesia/rigidity sub-score PDF
Cited by 0
OpenAlex
Reply to Matters Arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease PDF
Cited by 1
OpenAlex
In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease PDF
Cited by 31
OpenAlex
Phase 1/1b Studies of <scp>UCB0599</scp>, an Oral Inhibitor of α‐Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease PDF
Cited by 56
OpenAlex
Preclinical In Vivo Characterization of UCB0599, an Orally Available, Small Molecule Inhibitor of α-Synuclein Misfolding in Development for Parkinson’s Disease (S36.007)
Cited by 1
OpenAlex
Research Topics
Parkinson's Disease Mechanisms and Treatments
(5)
Autism Spectrum Disorder Research
(2)
Neurological disorders and treatments
(2)
Nuclear Receptors and Signaling
(2)
Nerve injury and regeneration
(1)
Affiliations
Statistics Belgium
GlaxoSmithKline (Belgium)
UCB Pharma (Belgium)